title: Do we need a new approach to making vaccine recommendations?
authors: Public Health Ontario, 480 University Avenue, Suite 300, Toronto M5S 1A8, Ontario, Canada natasha.crowcroft@oahpp.ca.
authors: Natasha S
authors: NS
authors: Crowcroft
authors: Dalla Lana School of Public Health, University of Toronto.
authors: Shelley L
authors: SL
authors: Deeks
authors: Dalla Lana School of Public Health, University of Toronto.
authors: Ross E
authors: RE
authors: Upshur
mesh_terms: D026683:Advisory Committees / Q000941:ethics; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017277:Drug Approval / Q000191:economics; D055808:Drug Discovery / Q000191:economics*; D004992:Ethics, Medical; D005381:Financing, Organized; D006801:Humans; D008585:Meningitis, Meningococcal / Q000191:economics / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000191:economics*; D014611:Vaccination / Q000191:economics
chemical_list: C570015:4CMenB vaccine; D022401:Meningococcal Vaccines